Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2343833 | 0.93 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL27864892 | 0.91 | LMNA (0.44) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL9310750 | 0.91 | SMN1; SMN2 (0.50) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL2347908 | 0.90 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL2350112 | 0.90 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL1101377 | 0.90 | ALDH1A1 (0.43) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL6131164 | 0.88 | SMN1; SMN2 (0.48) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL9120618 | 0.88 | ALDH1A1 (0.35) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL21161 | 0.87 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 | |
| SCHEMBL251421 | 0.87 | ALDH1A1 (0.38) | ALDH1A1SMN1; SMN2LMNATSHRHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 148 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741463-A1 | UV CURABLE COMPOSITIONS AND INKS | AGFA NV (BE) | 2026-05-13 | — | — | EP | disclosed |
| US-20260117083-A1 | ACTIVE ENERGY RAY-CURABLE INKJET BLACK INK AND PRINTED MATTER | ARTIENCE CO., LTD. (JP) | 2026-04-30 | — | — | US | disclosed |
| US-12610853-B2 | Curable composition for inkjet and air cavity formation, electronic component, and method for manufacturing electronic component | SEKISUI CHEMICAL CO., LTD. (JP) | 2026-04-21 | — | — | US | disclosed |
| US-12540252-B2 | Active energy ray-curable inkjet ink, and printed matter | ARTIENCE CO., LTD. (JP) | 2026-02-03 | — | — | US | disclosed |
| US-12528956-B2 | Ink-jet adhesive, method for producing electronic component, and electronic component | SEKISUI CHEMICAL CO., LTD. (JP) | 2026-01-20 | — | — | US | disclosed |
| EP-4269112-B1 | ULTRAVIOLET CURABLE INKJET INK SET AND PRODUCTION METHOD OF PRINTED MATTER | ARTIENCE CO LTD (JP) | 2025-10-08 | — | — | EP | disclosed |
| US-12421410-B2 | Active energy ray curable inkjet ink and active energy ray curable ink set | ARTIENCE CO., LTD. (JP) | 2025-09-23 | — | — | US | disclosed |
| CN-116133864-B | Ultraviolet curable inkjet ink set and method for producing printed matter | 爱天思株式会社 | 2025-05-09 | — | — | CN | disclosed |
| CN-113799486-B | Flow path member, liquid ejecting head, liquid ejecting apparatus, and method for manufacturing flow path member | 精工爱普生株式会社 | 2025-02-14 | — | — | CN | disclosed |
| CN-119452470-A | Method for manufacturing electronic component and electronic component | 积水化学工业株式会社 | 2025-02-14 | — | — | CN | disclosed |
| CN-101191027-A | Ink composition, two-pack curing ink composition set, and recording method and recorded matter using these | SEIKO EPSON CORP (JP) | 2008-06-04 | — | — | CN | disclosed |
| CN-101173127-A | Ink set | SEIKO EPSON CORP (JP) | 2008-05-07 | — | — | CN | disclosed |
| US-7344237-B2 | Recording liquid, liquid cartridge, liquid ejection cartridge, liquid ejection apparatus, and liquid ejection method | SONY CORPORATION (JP) | 2008-03-18 | — | — | US | disclosed |
| US-20070216740-A1 | RECORDING LIQUID, LIQUID CARTRIDGE EMITTING DEVICE AND LIQUID EMITTING METHOD | SONY CORPORATION (JP) | 2007-09-20 | — | — | US | disclosed |
| US-20070209551-A1 | RECORDING LIQUID, LIQUID CARTRIDGE EMITTING DEVICE AND LIQUID EMITTING METHOD | SONY CORPORATION (JP) | 2007-09-13 | — | — | US | disclosed |
| US-20070206080-A1 | RECORDING LIQUID, LIQUID CARTRIDGE, LIQUID EJECTION CARTRIDGE, LIQUID EJECTION APPARATUS, AND LIQUID EJECTION METHOD | SONY CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| US-20070206060-A1 | RECORDING LIQUID, LIQUID CARTRIDGE, LIQUID EJECTION CARTRIDGE, LIQUID EJECTION APPARATUS, AND LIQUID EJECTION METHOD | SONY CORPORATION (JP) | 2007-09-06 | — | — | US | disclosed |
| EP-1632539-A1 | RECORDING FLUID, CARTRIDGE FOR FLUID, DEVICE AND METHOD FOR DISCHARGING FLUID | Sony Corporation (JP) | 2006-03-08 | — | — | EP | disclosed |
| US-20050264629-A1 | Recording fluid, cartridge for fluid, device and method for discharging fluid | SONY CORPORATION (JP) | 2005-12-01 | — | — | US | disclosed |
| US-20050162457-A1 | Recording liquid, liquid cartridge, liquid ejection cartridge, liquid ejection apparatus, and liquid ejection method | SONY CORPORATION (JP) | 2005-07-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12528956-B2 | Ink-jet adhesive, method for producing electronic component, and electronic component | PTK2, ELL, BMI1 | ALDH1A1 1546/4885SMN1; SMN2 2073/4885LMNA 1774/4885 |
| US-12610853-B2 | Curable composition for inkjet and air cavity formation, electronic component, and method for manufacturing electronic component | MMAB, VCL, ACR | ALDH1A1 1903/4885SMN1; SMN2 2390/4885LMNA 1433/4885 |
| US-12540252-B2 | Active energy ray-curable inkjet ink, and printed matter | ACP1, MARK1, ACVRL1 | ALDH1A1 421/4885SMN1; SMN2 614/4885LMNA 1831/4885 |
| US-20260117083-A1 | ACTIVE ENERGY RAY-CURABLE INKJET BLACK INK AND PRINTED MATTER | MAPRE2, MAPRE1, HDLBP | ALDH1A1 1414/4885SMN1; SMN2 2281/4885LMNA 2087/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.